Belly Patch
NDC Package 85136-002-01
Package Information
Belly patches is indications for Use:· Relieve discomfort in the abdomen/back/waist.· Improve Blood Circulation· Relieve abdominal coldness and regulate gastrointestinal function.· anti-inflammatory effect.· Soothing Effect. This formulation utilizes a patch delivery system. Marketed by Henan Toudaorong Biotechnology Co., Ltd., this product is identified by NDC 85136-002 and is authorized under FDA application M017.
Identification & Billing
Clinical Specifications
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Food Additives - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 85136 - Henan Toudaorong Biotechnology Co., Ltd.
- 85136-002 - Belly
- 85136-002-01 - 15 PATCH in 1 BOX / 10 g in 1 PATCH
- 85136-002 - Belly
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85136-002-01 identifies a specific commercial package of 15 patch in 1 box / 10 g in 1 patch of Belly, a human over the counter drug labeled by Henan Toudaorong Biotechnology Co., Ltd.. This patch is formulated for topical use and contains camphor (natural); peppermint as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Henan Toudaorong Biotechnology Co., Ltd. on January 20, 2025. The current certification is valid through December 31, 2026.
How is this Henan Toudaorong Biotechnology Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85136000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.